1 Market Overview of Kidney/Renal Fibrosis Treatment 1.1 Kidney/Renal Fibrosis Treatment Market Overview 1.1.1 Kidney/Renal Fibrosis Treatment Product Scope 1.1.2 Market Status and Outlook 1.2 Global Kidney/Renal Fibrosis Treatment Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Kidney/Renal Fibrosis Treatment Market Size by Region (2015-2026) 1.4 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Region (2015-2020) 1.5 Global Kidney/Renal Fibrosis Treatment Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 1.6.1 North America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 1.6.2 Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 1.6.4 Latin America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) 2 Kidney/Renal Fibrosis Treatment Market Overview by Type 2.1 Global Kidney/Renal Fibrosis Treatment Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Type (2015-2020) 2.3 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2021-2026) 2.4 Angiotensin II Receptor Blockers (ARBs) 2.5 Angiotensin Converting Enzyme (ACE) Inhibitors 2.6 Pirfenidone 2.7 Renin Inhibitors 2.8 Vasopeptidase Inhibitors 3 Kidney/Renal Fibrosis Treatment Market Overview by Application 3.1 Global Kidney/Renal Fibrosis Treatment Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Kidney/Renal Fibrosis Treatment Historic Market Size by Application (2015-2020) 3.3 Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2021-2026) 3.4 Commercial/Private Hospitals 3.5 Public Health Hospitals 3.6 Clinics 3.7 Home Treatment 4 Global Kidney/Renal Fibrosis Treatment Competition Analysis by Players 4.1 Global Kidney/Renal Fibrosis Treatment Market Size by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019) 4.3 Date of Key Manufacturers Enter into Kidney/Renal Fibrosis Treatment Market 4.4 Global Top Players Kidney/Renal Fibrosis Treatment Headquarters and Area Served 4.5 Key Players Kidney/Renal Fibrosis Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Kidney/Renal Fibrosis Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Galectin Therapeutics 5.1.1 Galectin Therapeutics Profile 5.1.2 Galectin Therapeutics Main Business 5.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.1.4 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.1.5 Galectin Therapeutics Recent Developments 5.2 Merck & Co. 5.2.1 Merck & Co. Profile 5.2.2 Merck & Co. Main Business 5.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.2.4 Merck & Co. Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.2.5 Merck & Co. Recent Developments 5.3 F. Hoffman-La Roche Ltd. 5.5.1 F. Hoffman-La Roche Ltd. Profile 5.3.2 F. Hoffman-La Roche Ltd. Main Business 5.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.3.4 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.3.5 Pfizer Inc. Recent Developments 5.4 Pfizer Inc. 5.4.1 Pfizer Inc. Profile 5.4.2 Pfizer Inc. Main Business 5.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.4.4 Pfizer Inc. Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.4.5 Pfizer Inc. Recent Developments 5.5 InterMune Inc. 5.5.1 InterMune Inc. Profile 5.5.2 InterMune Inc. Main Business 5.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.5.4 InterMune Inc. Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.5.5 InterMune Inc. Recent Developments 5.6 ProMetic Life-Sciences Inc. 5.6.1 ProMetic Life-Sciences Inc. Profile 5.6.2 ProMetic Life-Sciences Inc. Main Business 5.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.6.4 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.6.5 ProMetic Life-Sciences Inc. Recent Developments 5.7 La Jolla Pharmaceutical Company 5.7.1 La Jolla Pharmaceutical Company Profile 5.7.2 La Jolla Pharmaceutical Company Main Business 5.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.7.4 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.7.5 La Jolla Pharmaceutical Company Recent Developments 5.8 Genzyme Corporation 5.8.1 Genzyme Corporation Profile 5.8.2 Genzyme Corporation Main Business 5.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.8.4 Genzyme Corporation Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.8.5 Genzyme Corporation Recent Developments 5.9 BioLine Rx Ltd 5.9.1 BioLine Rx Ltd Profile 5.9.2 BioLine Rx Ltd Main Business 5.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Products, Services and Solutions 5.9.4 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Revenue (US$ Million) & (2015-2020) 5.9.5 BioLine Rx Ltd Recent Developments 6 North America 6.1 North America Kidney/Renal Fibrosis Treatment Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Kidney/Renal Fibrosis Treatment Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Kidney/Renal Fibrosis Treatment Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Kidney/Renal Fibrosis Treatment Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Kidney/Renal Fibrosis Treatment Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Kidney/Renal Fibrosis Treatment Market Size by Region (2015-2020) (US$ Million) Table 3. Global Kidney/Renal Fibrosis Treatment Market Size Share by Region (2015-2020) Table 4. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size Share by Region (2021-2026) Table 6. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2015-2020) (US$ Million) Table 8. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2015-2020) Table 9. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Type (2021-2026) Table 11. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Kidney/Renal Fibrosis Treatment Market Size by Application (2015-2020) (US$ Million) Table 13. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2015-2020) Table 14. Global Kidney/Renal Fibrosis Treatment Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2021-2026) Table 16. Global Kidney/Renal Fibrosis Treatment Revenue (US$ Million) by Players (2015-2020) Table 17. Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2019) Table 19. Date of Key Manufacturers Enter into Kidney/Renal Fibrosis Treatment Market Table 20. Global Kidney/Renal Fibrosis Treatment Top Players Headquarters and Area Served Table 21. Kidney/Renal Fibrosis Treatment Product Solution and Service Table 22. Global Kidney/Renal Fibrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Galectin Therapeutics Basic Information List Table 25. Galectin Therapeutics Description and Business Overview Table 26. Galectin Therapeutics Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 27. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of Galectin Therapeutics (2015-2020) Table 28. Galectin Therapeutics Recent Developments Table 29. Merck & Co. Basic Information List Table 30. Merck & Co. Description and Business Overview Table 31. Merck & Co. Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 32. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of Merck & Co. (2015-2020) Table 33. Merck & Co. Recent Developments Table 34. F. Hoffman-La Roche Ltd. Basic Information List Table 35. F. Hoffman-La Roche Ltd. Description and Business Overview Table 36. F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 37. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of F. Hoffman-La Roche Ltd. (2015-2020) Table 38. F. Hoffman-La Roche Ltd. Recent Developments Table 39. Pfizer Inc. Basic Information List Table 40. Pfizer Inc. Description and Business Overview Table 41. Pfizer Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 42. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of Pfizer Inc. (2015-2020) Table 43. Pfizer Inc. Recent Developments Table 44. InterMune Inc. Basic Information List Table 45. InterMune Inc. Description and Business Overview Table 46. InterMune Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 47. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of InterMune Inc. (2015-2020) Table 48. InterMune Inc. Recent Developments Table 49. ProMetic Life-Sciences Inc. Basic Information List Table 50. ProMetic Life-Sciences Inc. Description and Business Overview Table 51. ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 52. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of ProMetic Life-Sciences Inc. (2015-2020) Table 53. ProMetic Life-Sciences Inc. Recent Developments Table 54. La Jolla Pharmaceutical Company Basic Information List Table 55. La Jolla Pharmaceutical Company Description and Business Overview Table 56. La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 57. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of La Jolla Pharmaceutical Company (2015-2020) Table 58. La Jolla Pharmaceutical Company Recent Developments Table 59. Genzyme Corporation Basic Information List Table 60. Genzyme Corporation Description and Business Overview Table 61. Genzyme Corporation Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 62. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of Genzyme Corporation (2015-2020) Table 63. Genzyme Corporation Recent Developments Table 64. BioLine Rx Ltd Basic Information List Table 65. BioLine Rx Ltd Description and Business Overview Table 66. BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Products, Services and Solutions Table 67. Revenue (Million US$) in Kidney/Renal Fibrosis Treatment Business of BioLine Rx Ltd (2015-2020) Table 68. BioLine Rx Ltd Recent Developments Table 69. North America Kidney/Renal Fibrosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 70. North America Kidney/Renal Fibrosis Treatment Market Size Share by Country (2015-2020) Table 71. Europe Kidney/Renal Fibrosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 72. Europe Kidney/Renal Fibrosis Treatment Market Size Share by Country (2015-2020) Table 73. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size by Region (2015-2020) & (US$ Million) Table 74. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size Share by Region (2015-2020) (US$ Million) Table 75. Latin America Kidney/Renal Fibrosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 76. Latin America Kidney/Renal Fibrosis Treatment Market Size Share by Country (2015-2020) (US$ Million) Table 77. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size by Players (2015-2020) (US$ Million) Table 78. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size Share by Players (2015-2020) (US$ Million) Table 79. Kidney/Renal Fibrosis Treatment Market Trends Table 80. Kidney/Renal Fibrosis Treatment Market Drivers Table 81. Kidney/Renal Fibrosis Treatment Market Challenges Table 82. Kidney/Renal Fibrosis Treatment Market Restriants Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Kidney/Renal Fibrosis Treatment Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Kidney/Renal Fibrosis Treatment Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Kidney/Renal Fibrosis Treatment Market Share by Regions: 2020 VS 2026 Figure 4. North America Kidney/Renal Fibrosis Treatment Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Kidney/Renal Fibrosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Kidney/Renal Fibrosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Kidney/Renal Fibrosis Treatment Market Share by Type in 2020 & 2026 Figure 10. Angiotensin II Receptor Blockers (ARBs) Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Pirfenidone Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Renin Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Vasopeptidase Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Global Kidney/Renal Fibrosis Treatment Market Size Share by Application in 2020 & 2026 Figure 16. Commercial/Private Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Public Health Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Clinics Market Size (US$ Million) YoY Growth (2015-2026) Figure 19. Home Treatment Market Size (US$ Million) YoY Growth (2015-2026) Figure 20. Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Top 5 and Top 10 Players Kidney/Renal Fibrosis Treatment Market Share in 2019 Figure 22. United States Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Canada Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Germany Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. France Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. U.K. Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Italy Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Russia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Nordic Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Rest of Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. China Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Japan Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. South Korea Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Southeast Asia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. India Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Australia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Mexico Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Brazil Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Latin America Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Turkey Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Saudi Arabia Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. UAE Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Rest of Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation

Galectin Therapeutics Merck & Co. F. Hoffman-La Roche Ltd. Pfizer Inc. InterMune Inc. ProMetic Life-Sciences Inc. La Jolla Pharmaceutical Company Genzyme Corporation BioLine Rx Ltd